Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ACOR, TIBX, CRWE, DISH - Stock Report From DrStockPick.com!

drstock-2-3

signup3m

Crown Equity Holdings Inc. (OTCBB:CRWE) is pleased to report its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009. The Company incurred an operating loss of $54,527 for the nine months ending September 30, 2010 compared to an operating loss of $36,923 during the same period in 2009. Net loss of $343,049 for the nine months ending September 30, 2010 compared to a net loss of $29,379 for the same period in 2009. The net loss in 2010 was attributed mostly to an unrealized loss of $307,544 on securities held by the Company.

Crown Equity Holdings Inc. is extending its internet footprint internationally to include the following countries; Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Indonesia, Italy, Japan, Korea, Malaysia, Mexico, New Zealand, Pakistan, Russia, Singapore, Spain, South Africa, Taiwan, United Arab Emirates and United Kingdom.

Crown Equity Holdings Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients. The company announced in June of this year its 1- 10 forward stock split.

One Internet advertising benefit is that, since the internet spans the globe, pockets of your target market scattered around the world can all be targetted at once, rather than trying to find different publications, radio stations and television stations that cater to a particular geographical area.

Information published on the World Wide Web is automatically offered to a global audience of consumers. This does make the net an incredibly cost-effective medium to get information out to readers, reaching over 190 countries.

**********************************************

Dish Network Corp. (Nasdaq:DISH) reaffirmed its commitment to growing its selection of movie channels with the launch of Starz Entertainment’s MoviePlex movie channel into DISH Network’s HD Platinum package. As part of the multi-year agreement signed between the companies, MoviePlex’s content, along with hundreds of titles from Starz and Encore, will also soon be available on demand and through DISHOnline.com.

DISH Network Corporation, through its subsidiaries, provides DISH Network subscription television services in the United States. The company operates the DISH Network television service, which provides a direct broadcast satellite subscription television services.

**********************************************

Tibco Software, Inc. (Nasdaq:TIBX) has been named a Leader in the November 2010 report by Forrester Research, Inc., The Forrester Wave™: Comprehensive Integration Solutions, Q4 2010. The evaluation of TIBCO in this report is based on current offering, strategy, and market presence.

TIBCO Software Inc. provides infrastructure software solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company offers its products in the areas of service-oriented architecture (NYSE:SOA), business optimization, and business process management (BPM).

**********************************************

Acorda Therapeutics, Inc. (Nasdaq:ACOR) announced that the first patient has been enrolled in the first clinical trial of Glial Growth Factor 2 (GGF2). Acorda is collaborating with the Vanderbilt University Heart and Vascular Institute to conduct this Phase 1 single-dose trial in patients with heart failure

Acorda Therapeutics, Inc., a biotechnology company, develops therapies for multiple sclerosis, spinal cord injury, and other nervous system disorders. Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with multiple sclerosis; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

*******************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

drstbc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.